Olmesartan/Amlodipine fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olmesartan/Amlodipine fixed-dose combination, covering 2017-02-23 to 2017-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg [Phase 4]